About the Company
We do not have any company description for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug ...
Creative Medical Technology Holdings, Inc., a leader in the field of regenerative medicine with a focus on developing novel therapies in immunotherapy, endocrinology, urology, gynecology, and ...
Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain
This designation positions CELZ-201-DDT among a select group of therapies recognized for their potential to address serious medical conditions with high unmet need. Fast Track status enables the ...
Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT ...
PHOENIX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology leader in regenerative medicine, is pleased to announce the successful ...
Retail Traders Pile Into Creative Medical After FDA Fast Tracks Degenerative Disc Disease Therapy
Retail chatter around Creative Medical Technology Holdings picked up on Wednesday after the company said the U.S. Food and ...
Is Creative Medical Technology Holdings, Inc. (CELZ) Stock ... - Nasdaq
Creative Medical Technology Holdings, Inc. is currently sporting a Zacks Rank of #2 (Buy). Within the past quarter, the Zacks Consensus Estimate for CELZ's full-year earnings has moved 9.4% higher.
Creative Medical Technology Holdings Announces Successful Completion of ...
Creative Medical Technology Holdings, Inc. is a biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy ...
Creative Medical Technology Holdings Inc. Announces FDA Authorization ...
PHOENIX-- (BUSINESS WIRE)-- Creative Medical Technology Holdings, Inc., (NASDAQ:CELZ), a leader in biotech innovation, today announced a major stride in combating Type 1 Diabetes Mellitus (T1D).
Creative Medical Technology Holdings Receives Notice of ... - ABC27
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) is a clinical-stage biotechnology company pioneering regenerative medicine solutions for multiple indications, including pain management ...
Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug ...
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) is dedicated to progressing CELZ-101 through the necessary regulatory pathways, with the goal of transforming the therapeutic landscape for ...
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Short Interest ...
Creative Medical Technology has a twelve month low of $2.65 and a twelve month high of $10.28. The firm has a market capitalization of $5.70 million, a P/E ratio of -1.23 and a beta of 2.09.
Similar Companies
Loading the latest forecasts...